CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Ultragenyx Pharmaceutical Inc Company Snapshot
Ultragenyx Pharmaceutical Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ultragenyx Pharmaceutical Inc with three other companies in this sector in UNITED STATES : NGM Biopharmaceuticals Inc (2019 sales of $103.54 million of which 100% was Clinical-stage biopharmaceutical company), Athenex Inc ($101.23 million of which 50% was Commercial Platform), and Catalyst Pharmaceuticals Inc ($102.31 million of which 100% was Prescription Drugs).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Ultragenyx Pharmaceutical Inc
  Stock Performance Chart for Ultragenyx Pharmaceutical Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 84.84
(Figures in U.S. Dollars)
1 Week 8.5%   13 Weeks -1.6%  
4 Weeks 32.9%   52 Weeks 39.1%  
 
Ultragenyx Pharmaceutical Inc Key Data:
  Ticker: RARE Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 103,714,000
(Year Ending Jan 2020).
Employees: 740
  Currency: U.S. Dollars Market Cap: 5,125,503,059
  Fiscal Yr Ends: December Shares Outstanding: 60,413,756
  Share Type: Common Closely Held Shares: 3,617,790
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.